Dec 26 Chhattisgarh has recorded zero dengue deaths in 2025 a major public health milestone after several challenging years. In 2018, the tribal state reported 5,294 cases and 83 deaths, including a maximum of 53 in the twin cities of Bhilai-Nagar-Durg. Even in 2024, the state saw 3,523 cases and two deaths from this vector-borne disease. Notably, all districts have reported a sharp drop in cases compared to previous years.

 

According to the latest data from the National Vector Borne Disease Control Programme under Chhattisgarh’s Department of Health and Family Welfare, the state recorded 336 dengue cases from January 1 to December 20, 2025 with zero deaths. This reflects a drop of over 90% in cases compared to 2024’s 3,523 cases and two deaths. Historical trends show volatility: In 2019, cases fell sharply to 722 with one death; 2020 had just 57 cases and zero deaths. However, cases rose again in 2021 (1,080 cases, two deaths), 2022 (2,679 cases, ten deaths), and 2023 (2,412 cases, three deaths). This achievement stands out against neighbouring states Maharashtra and Telangana, which reported over 5,000 cases each till November 2025,

 

Maharashtra with 12 deaths and Telangana with seven. Nationally, India recorded 113,400 dengue cases and 94 deaths in the first 11 months of 2025. Chhattisgarh ranks 16th in fresh cases among states and is one among seven states/UTs with zero deaths. At present, Chhattisgarh is one of the seven states as well as union territories in the country where not a single death from it has been reported so far. Districts like Surguja, Bastar, and Durg have particularly succeeded in controlling outbreaks.

 

Even in Dhamtari and Mahasamund districts, National Vector Control Programme has registered a drop of over 90% in cases of dengue in 2025 as compared to previous year: 2024. Dr S P Mandal, the state’s dengue and malaria specialist, noted that Chhattisgarh’s 2025 case fatality rate of 0.005% is far below the national rate of 0.08%. Dr Jitendra Kumar, State Vector Borne Disease Officer, attributed the success to strengthened surveillance, early diagnosis, integrated vector management, intensive awareness campaigns, and free testing for all patients.